BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
8 hedge funds and large institutions have $4.31M invested in BriaCell Therapeutics Corp Warrant in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
173% more capital invested
Capital invested by funds: $1.58M → $4.31M (+$2.73M)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less funds holding
Funds holding: 10 → 8 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
102% less ownership
Funds ownership: 114.02% → 12.01% (-102%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$379K |
| 2 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$286K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$377K |
| 2 |
VF
Virtu Financial
New York
|
-$19K |
| 3 |
IP
Intellectus Partners
San Francisco,
California
|
-$18K |
| 4 |
Jane Street
New York
|
-$18K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$12.3K |
BCTXW Hedge Fund Activity: Q3 2021 in Review
8 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q3 2021, worth a combined $4.31M — up 173% from $1.58M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BCTXW and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Murchinson, adding an estimated $379K. The largest seller was Altium Capital Management, exiting entirely with an estimated $377K sold.
- 8 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q3 2021, down from 10 in Q2 2021.
- Funds reported $4.31M of BriaCell Therapeutics Corp Warrant stock for Q3 2021, up 173% quarter-over-quarter.
- 2 funds opened new BriaCell Therapeutics Corp Warrant positions in Q3 2021 and 4 closed out, a net change of -2 holders.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q3 2021 was Murchinson, an estimated $379K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q3 2021 was Altium Capital Management, an estimated $377K sold.
Based on aggregated 13F filings for Q3 2021.